ArticleBreast cancer research and treatment2023

CDK4/6 inhibitors versus weekly paclitaxel for treatment of ER+/HER2- advanced breast cancer with impending or established visceral crisis.

Roya Behrouzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.